TaraAAltepeterMD
Pediatric Gastroenterology • Silver Spring, MDAssociate Director for Therapeutic Review
Dr. Altepeter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10903 New Hampshire Ave
Silver Spring, MD 20993Phone+1 240-402-2458- Is this information wrong?
Summary
- Dr. Altepeter leads a team of physicians and scientists in the Office of New Drugs, at FDA's Center for Drug Evaluation and Research (CDER) in the Division of Gastroenterology. Her interests include Inflammatory Bowel Disease, functional GI disorders, and pediatric drug development.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonFellowship, Pediatric Gastroenterology, 2012 - 2015
Advocate Health Care/Advocate Children’s Hospital (Oak Lawn)Residency, Pediatrics, 2008 - 2011
University of Illinois College of MedicineClass of 2008
Certifications & Licensure
DC State Medical License 2015 - 2024
DE State Medical License 2012 - 2016
IL State Medical License 2008 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- 2 citationsImmune-mediated colitis associated with ocrelizumab: A new safety risk.Tiffany Kim, Allen Brinker, David Croteau, Paul R Lee, Laura E Baldassari, Jessica Stevens, Alice Hughes, Juli Tomaino, Arushi deFonseka, Tara Altepeter, Cindy M Korte...> ;Multiple Sclerosis. 2023 Sep 1
- 7 citationsPaediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents.Nicholas M Croft, Lissy de Ridder, Anne M Griffiths, Jeffrey S Hyams, Frank M Ruemmele, Dan Turner, Katharine Cheng, Irja Lutsar, Marco Greco, Zuzanna Gołębiewska, Flo...> ;Journal of Crohn's & Colitis. 2023 Mar 18
- 2 citationsModel-Informed Approach Supporting Approval of Adalimumab (HUMIRA) in Pediatric Patients with Ulcerative Colitis from a Regulatory Perspective.Ruo-Jing Li, Lian Ma, Hyewon Kim, Insook Kim, Lesley Hanes, Tara Altepeter, Jessica Lee, Jiang Liu, Hao Zhu, Yaning Wang> ;The AAPS Journal. 2022 Jul 6
- Join now to see all
Press Mentions
New Bowel Disorder Treatments Needed, FDA SaysApril 17th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
